CLINICAL_TRIALS
trial_result
· 2020-01-02
Clinical Trial Update: A Study to Assess the Efficacy and Safety of Abatacept in Adults With Active Primary Sjögrens Syndrome [Phase 3]
Summary
Phase 3 trial evaluating abatacept for active primary Sjögren's syndrome has completed; results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Sjogrens Disease | Phase 3 | Status: COMPLETED | Results posted: 2020-01-02